Retraction of “Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy”

Detalles Bibliográficos
Autores principales: Wang, Jia-Yang, Song, Ya-Qi, Peng, Jing, Luo, Hong-Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320148/
https://www.ncbi.nlm.nih.gov/pubmed/34337271
http://dx.doi.org/10.1021/acsomega.1c02888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320148/
https://www.ncbi.nlm.nih.gov/pubmed/34337271
http://dx.doi.org/10.1021/acsomega.1c02888

Ejemplares similares